HYDRINITY Accelerated Skin Science Expands into Benelux

BY PR Newswire | ECONOMIC | 03/11/25 08:31 AM EDT

The company is proud to announce the new partnership with Den Medical of Belgium

NASHVILLE, Tenn., March 11, 2025 /PRNewswire/ -- Today, HYDRINITY Accelerated Skin Science, the fastest growing professional skincare brand in the US, is proud to announce their new partnership with Den Esthetics, a division of Den Medical of Belgium, a premier provider of the highest-quality medical products and brands in the Benelux region ? comprising of Belgium, Netherlands, and Luxembourg.

Benelux is an economically prosperous region within Europe, with a significant contribution to both GDP and the skincare market which is projected to grow to over $1.7 billion by the end of 2025*, indicating growing consumer demand and increasing awareness of skincare products in the region.?

"We are excited to partner with Den Medical of Belgium who has an exceptional reputation among leading dermatologists, plastic surgeons, and aesthetics providers in Benelux. Their team thoroughly researched and carefully crafted a strategic plan for HYDRINITY making them an excellent partner in this important and influential area of Northern Europe," said Brent Nixon, COO of HYDRINITY.

HYDRINITY is known for formulating skincare products with only the highest quality pharmaceutical-grade ingredients, making the brand a natural fit in this premiere market and their consumers. Benelux has the highest per capita spending in Europe and is amongst the highest in the world* with over 30 million people and over 2,000 aesthetic physicians offering substantial growth potential in this affluent region.

"We have been observing HYDRINITY for over 18 months and believe this notable skincare brand provides an outstanding opportunity for our market. The exceptional, leading-edge technology and clinical outcomes that have made HYDRINITY a market leader around the world will do the same here in Benelux. Our team is confident they will establish HYDRINITY as a leading brand in the premium skincare market in the coming years," stated Alain Mampuya, CEO of Den Medical.

For more information about HYDRINITY Accelerated Skin Science, visit on Instagram,https://www.facebook.com/hydrinity?TikTok, Facebook,?or?hydrinity.com.

For more information about Den Medical of Belgium, visit on denmedical.eu?or denesthetics.eu.

For more information on HYDRINITY in the Benelux, visit?hydrinitybenelux.com or?Instagram.

About HYDRINITY Accelerated Skin Science:
HYDRINITY Accelerated Skin Science, the fastest growing professional skincare brand in the US, began as a regenerative medicine company developing advanced wound care products and drug delivery systems for oncology and hematology patients. Since launching in 2022, HYDRINITY Accelerated Skin Science has become the leader in hyaluronic acid technology introducing clinically backed formulations that contain Supercharged injectable-grade hyaluronic acid and other patented and proprietary technologies able to penetrate deep into the dermal layers of the skin. Today, HYDRINITY is available in over 3,000 professional practices and 22 countries globally and is rapidly expanding.

About Den Medical:
Den Medical is recognized as a premier provider of the highest-quality medical products and brands in the fields of chronic pain therapy, gynecology and esthetic medicine, covering the Benelux region ? comprising of Belgium, Netherlands, and Luxembourg. By offering expertise and quality services, Den Medical's Den Esthetics division stands out amongst the medical community by working with dermatologists, plastic surgeons, skin therapists and physiotherapists who offer aesthetics treatments for skin rejuvenation and skin improvement such as scarred tissue, acne scars and stretch marks.

*Statista Market Insights 2025

For media inquiries, please contact Rebel Gail Communications
Stephanie Channell | 391030@email4pr.com?| 212.675.8555

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/hydrinity-accelerated-skin-science-expands-into-benelux-302397209.html

SOURCE HYDRINITY Accelerated Skin Science

In general the bond market is volatile, and fixed income securities carry interest rate risk. (As interest rates rise, bond prices usually fall, and vice versa. This effect is usually more pronounced for longer-term securities.) Fixed income securities also carry inflation risk and credit and default risks for both issuers and counterparties. Unlike individual bonds, most bond funds do not have a maturity date, so avoiding losses caused by price volatility by holding them until maturity is not possible.

Lower-quality debt securities generally offer higher yields, but also involve greater risk of default or price changes due to potential changes in the credit quality of the issuer. Any fixed income security sold or redeemed prior to maturity may be subject to loss.

Before investing, consider the funds' investment objectives, risks, charges, and expenses. Contact Fidelity for a prospectus or, if available, a summary prospectus containing this information. Read it carefully.

fir_news_article